Skin anti-aging technology company Cytrellis completed $28.5 million in Series B financing

Arterial Network learned that in early June, medical and beauty technology company Cytrellis Biosystems completed $28.5 million in Series B financing. The investment institutions included the last round of investment ARCH Venture Partners, the Merz Venture Initiative, and the new investors Partner Fund Management and BioMatics Capital.

The company's three female co-founders

After the completion of the financing, Michael Peterson, chief technology officer of the equipment company of Merz Venture Initiative, will join the board of directors.

“We are pleased to complete this important financing, which will enable the company to complete follow-up clinical research and fund our regulatory approvals,” said Karen Cronholm, President and CEO of Cytrellis. “In addition, we welcome Mr. Peterson. Providing professional technical support, he has been involved in leading the development of a variety of dermatological equipment, including the famous Ultherapy? and Cellfina?"

According to the data, Cytrellis Biosystems is located in Massachusetts, USA. The core technology of the company is proprietary micro-resection skin technology, which creates a new treatment for skin diseases in addition to optoelectronics and surgery.

More specifically, this technology is not based on traditional energy, energy-based therapies, using optoelectronic means to try and repair damaged skin, but they have limited effectiveness or require long healing times and cannot be significantly reduced or removed. To relax the skin, the patient must undergo surgery to remove unwanted skin and reduce sagging skin.

According to the American Society of Plastic Surgery (ASAPS), Americans spent more than $15 billion on beauty in 2016, an increase of 11% over 2015. Despite the progress made in the medical beauty industry in the past decade, there is still no means to remove unwanted skin without surgery without scarring.

Cytrellis Biosystems is not based on current mainstream optoelectronics

The Cytrellis system, which includes a handheld device and consumables, handles large facial skin in a precise and user-friendly manner. The device also includes a skin coring mechanism that precisely controls the position and depth of the micro-cut.

According to official website data, 80 subjects experienced good skin tissue healing after 90 days of minimally invasive surgery. The pain level during treatment was 0.36, the pain was very light, and the overall improvement was satisfied with 93%.

90-day clinical effect of Cytrellis treatment

After this round of financing, the company will carry out a clinical research work and obtain regulatory qualifications.

Organic Matcha

Organic Matcha powder is a form of green tea. Its name is derived from the Chinese words, [cha" (tea) and [ma" (powder), and like all other true teas, comes from the Camellia sinensis plant. Matcha refers to the method in which the leaves are grown and processed. Organic green tea is grown in the high mountains, due to the geographical advantage of high altitude, our green tea contains up to 20% tea polyphenols, and tea polyphenols have good anti-oxidation and anti-aging effects.

Organic Matcha Powder,Organic Matcha,Orgnaic Matcha Green Tea,Matcha Green Tea Powder

Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com